期刊文献+

帕利哌酮利培酮喹硫平治疗精神分裂症对照研究 被引量:5

A control study among palperidone, risperidone and quetiapine in the treatment of schizophrenia
下载PDF
导出
摘要 目的 比较帕利哌酮、利培酮、喹硫平治疗精神分裂症的临床疗效、安全性及对患者社会功能的影响.方法 将180例精神分裂症患者随机分为3组,每组60例,分别口服帕利哌酮、利培酮和喹硫平治疗,观察12周.采用阳性与阴性症状量表、个人和社会功能量表及副反应量表评定临床疗效、社会功能及不良反应.结果 治疗8周、12周末帕利哌酮组阳性与阴性症状量表评分显著低于利培酮组和喹硫平组,个人和社会功能量表评分显著高于利培酮组和喹硫平组(P<0.01);治疗12周末,3组临床疗效比较差异无显著性(P>0.05);帕利哌酮组与利培酮组主要不良反应为震颤、静坐不能,喹硫平组为体质量增加、心动过速.结论帕利哌酮、利培酮、喹硫平治疗精神分裂症疗效显著且相当,但帕利哌酮在控制精神症状,改善社会功能方面优于利培酮及喹硫平,且安全性更高.
出处 《临床心身疾病杂志》 CAS 2013年第4期316-319,共4页 Journal of Clinical Psychosomatic Diseases
基金 佛山市医学科学技术研究基金资助项目(201008216)
  • 相关文献

参考文献14

二级参考文献30

  • 1吴仁容,李乐华.新型抗精神病药:阿立哌唑[J].国外医学(精神病学分册),2004,31(3):177-179. 被引量:380
  • 2朱紫青.国际资深专家谈抗精神病药物治疗的新进展[J].上海精神医学,2005,17(B09):79-80. 被引量:4
  • 3陈晋东,赵靖平,李乐华,国效峰,吴仁容,翟金国,王传跃,谢世平,高成阁,丁瑛,陈远光.阿立哌唑治疗精神分裂症的多中心随机双盲对照试验[J].中国新药与临床杂志,2005,24(11):845-848. 被引量:65
  • 4赖文琴,张程赪.健康教育对恢复期精神分裂症患者预后的影响[J].临床心身疾病杂志,2006,12(3):173-174. 被引量:24
  • 5童建明,杨正春.阿立哌唑与利培酮治疗精神分裂症对照研究[J].临床心身疾病杂志,2007,13(1):7-10. 被引量:22
  • 6Inouc A, Seto M, Sugita S, et al. Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and airpiprazole in the rat pituitary[J]. Brain Res, 1998,55:285
  • 7Paul Mackin,David R Bishop,Helen MoWatkinson.A prespective study of monitoring practices for metabolic disease in antipsychotic treated community psychiatric patient[J].BMC Psychiatric,2007,7:28.
  • 8M Srisurapanont,S Likhitsathian,V Boonyanaruthee,et al.Metabolic syndrome in Thai schizophrenic patients:a naturalisticone 2 year follow up study[J].BMC psychiatry,2007,7:242.
  • 9Mcevoy JP,Meyer JM,Goff DC,et al.Prevalence of the metabolic syndrome in patients with schizophrenia:baseline results from the clinical antipsychotic trials of intervention effectiveness(CATIE) schizophrenic trial and comparison with national estimates from NHANES Ⅲ[J].Schizophr Res,2005:80:19.
  • 10Alberti KG,MM Zimmet.PZ for the WHO consutation.Definition diagnosis and classification of diabetes mellitus and its comp licationpart1:diagnosis and classification of diabetes mellitus provisional report of a who consultation[M].Diabetic medicine,1998:539-553.

共引文献53

同被引文献42

  • 1黄继伟,吕维忠,何益群.氨磺必利与利培酮治疗首发精神分裂症对照研究[J].临床心身疾病杂志,2013,19(4):343-313. 被引量:39
  • 2张永福,张海风,谷伟.阿立哌唑治疗儿童精神分裂症对照研究[J].临床心身疾病杂志,2007,13(2):122-124. 被引量:4
  • 3American Psychiation Association. Diagnostic and statistical manual of mental disorders [ M ]. 4th ed. Washington: APA. 1994:273 292.
  • 4Janick PG, Winans EA. Paliperidone ER. a review of the clinical trial data [J]. Neuropsychiatr Dis Treat, 2007, 3 (6) . 869.
  • 5Davidson M, Emsley R, Kramer, et al. Efficacy, safe- ty and early response of paliperidone extended release tablets (paliperidone ER): results of a 6-week randomized, placebo- controlled study EJ]. Schizophre Res, 2007, 93 (1 3): 117.
  • 6Marder SR, Kramer M, Ford L, et al. Efficacy and safety of paliperidone extended-release tablets: results of a 6- week, randomized, placebo-controlled study [J]. Biol Psy- chiatry, 2007, 62(12): 1363.
  • 7Kane J, Canas F, Kramer M, et al. Treatment of schiz ophrenia with paliperidone extended-release tablets: a 6- week placebo controlled trial [J]. Schizophr Res, 2007, 90 (1--3) : 147.
  • 8Davidson M, Emsley R, Kramer M, et al. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER):results of a 6-week, randomized, placebo-controlled study [J]. Schizophr Res, 2007, 93 (1 3) .. 117.
  • 9Canuso C, Dirks B, Carothers J, et ah Randomized, double-blind, placebo-controlled study of paliperidone ex tended-release and quetiapine in inpatients with recently ex acerbated schizophrenia[J]. Am J Psychiatry, 2009,166 (6): 691.
  • 10Riedel M, Schwarz MJ, Strassnig M, et al. Risperi- done plasma levels, clinical response and side effects [J]. Eur Arch Psychiatry Clin Neurosci, 2005, 255 (4) : 261.

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部